Sign inJoin waitlistJoin the waitlist

Bradley Lash

Chief, Hematology-Medical Oncology · Lehigh Valley Health Network

Credentials: · · · · ·

History

Hematology-Medical Oncology Division · Lehigh Valley Health Network
Present

Main Line Health Lankenau Medical Center
2009–2012
Internal Medicine
Robert Packer Hospital
2006–2009
State University of New York Upstate Medical University
2002–2006

Research

Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study
Journal of Clinical Oncology · 2019 · 147 citations
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma
Journal of Clinical Oncology · 2023 · 101 citations
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Journal of Clinical Oncology · 2022 · 94 citations

Zachary Wolfe
5 papers · 5 as a resident
BB
Bernard Bochner
3 papers
DB
Dean Bajorin
3 papers
EC
Eugene Cha
3 papers
Eugene Pietzak
3 papers · 3 as a resident
GI
Gopa Iyer
3 papers
HH
Harry Herr
3 papers
HA
Hikmat Al-Ahmadie
3 papers
Jeffrey Kamradt
3 papers
SD
Sherri Donat
3 papers
TD
Timothy Donahue
3 papers
Andrea Apolo
2 papers

Clinical trials

The Safety of a High-Dose, Rapid Infusion of Iron Sucrose
Principal investigator · Withdrawn · Phase 2
The Guthrie Clinic
2017